All In MedTech

Device Trial Radar · NCT03873714

Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE)

A Study of the Pipeline™ Vantage Embolization Device With Shield Technology™ for Endovascular Treatment of Wide-Necked Intracranial Aneurysms

Last checked: Nov 20, 2026Latest source record: Jun 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

14

Actual

Start

Apr 2, 2020

Primary completion

Jul 22, 2021

Study completion Sep 18, 2023

Sponsor

Sponsor type
Industry
First posted
Mar 13, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety and effectiveness of the Pipeline™ Vantage Embolization Device with Shield Technology™ in the treatment of intracranial aneurysms within the intended indication for use.

Conditions

  • Intracranial Aneurysm

Interventions

  • Pipeline™ Vantage Embolization Device with Shield Technology™Device

    Pipeline™ Vantage Embolization Device with Shield Technology™

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety: Incidence of Major Stroke or Neurological DeathTime frame: 1 year post-procedure
  2. Effectiveness: Incidence of Complete Aneurysm OcclusionTime frame: 1 year post-procedure

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Baptist Medical Center Jacksonville

    Jacksonville, Florida

  • Jackson Memorial Hospital

    Miami, Florida

  • Stony Brook University Hospital

    Stony Brook, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.